Klebsiella pneumoniae with Two Carbapenemases: Where Molecular Research Stands Now

Qian Yu1, Gaosha Li1, Qianqian Xu2

  • 1Department of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine (Jinhua Municipal Central Hospital), Jinhua, Zhejiang, People's Republic of China.

PubMed

Insights

Carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a global threat due to carbapenemase enzymes. Understanding enzyme combinations and mobile genetic elements is crucial for combating CRKP infections and antimicrobial resistance.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genetics

Background:

  • Klebsiella pneumoniae is a major cause of hospital-acquired infections.
  • Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged as a significant global health concern since the 1990s.
  • Carbapenemase production is the primary mechanism of resistance in CRKP.

Purpose of the Study:

  • To review major carbapenemases in Klebsiella pneumoniae.
  • To summarize global spread and plasmid-mediated co-occurrence of carbapenemase genes.
  • To discuss genetic environments and transfer characteristics of common CRKP enzyme combinations.

Main Methods:

  • Literature review of studies on carbapenemases in Klebsiella pneumoniae.
  • Analysis of reported CRKP enzyme type combinations and their plasmids.
  • Discussion of whole genome sequencing's role in resistance gene identification.

Main Results:

  • KPC is the most prevalent carbapenemase in China, followed by metallo-beta-lactamases (MBLs).
  • Increasing CRKP strains exhibit multiple carbapenemase types, complicating resistance.
  • Common combinations include KPC + MBL, bimetallic enzymes, and MBL + OXA-48, often on mobile genetic elements like plasmids.

Conclusions:

  • Resistance genes in Klebsiella pneumoniae are frequently located on mobile genetic elements, particularly plasmids.
  • Plasmids carrying multiple resistance genes exhibit high transfer rates with minimal host impact.
  • Preventing multi-drug resistant Klebsiella pneumoniae requires rational antibiotic use, early surveillance, and resistance trend prediction.